Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cells

被引:29
作者
Herzer, K
Ganten, TM
Schulze-Bergkamen, H
Grosse-Wilde, A
Koschny, R
Krammer, PH
Walczak, H
机构
[1] Deutsch Krebsforschungszentrum, Div Apoptosis Regulat D040, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Div Immunogenet, D-69120 Heidelberg, Germany
关键词
D O I
10.1002/hep.20757
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transforming growth factor beta (TGF-beta) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. However, the exact mechanism through which TGF-beta induces cell death is still unknown. We examined a potential role of various death receptor/ ligand systems in TGF-beta-induced apoptosis and identified the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a mediator of TGF-beta-induced apoptosis in hepatoma cells. TGF-beta-induced apoptosis is significantly impaired upon blockage of TRAIL. We show that TRAIL is upregulated in hepatoma cells upon treatment with TGF-beta, whereas TRAIL receptor levels remain unchanged. In conclusion, our results provide evidence that the TRAIL system is critically involved in TGF-beta-induced cell death in liver pathology.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 51 条
[1]   TGF-β signaling in cancer -: a double-edged sword [J].
Akhurst, RJ ;
Derynck, R .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51
[2]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[4]   Regulation of tumour necrosis factor α mRNA stability by the mitogen-activated protein kinase p38 signalling cascade [J].
Brook, M ;
Sully, G ;
Clark, AR ;
Saklatvala, J .
FEBS LETTERS, 2000, 483 (01) :57-61
[5]   GROWTH MODULATORY EFFECTS OF A LIVER-DERIVED GROWTH INHIBITOR, TRANSFORMING GROWTH FACTOR-BETA-1, AND RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA, IN NORMAL AND NEOPLASTIC-CELLS [J].
CHAPEKAR, MS ;
HUGGETT, AC ;
THORGEIRSSON, SS .
EXPERIMENTAL CELL RESEARCH, 1989, 185 (01) :247-257
[6]   Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[7]   The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain [J].
Degli-Esposti, MA ;
Dougall, WC ;
Smolak, PJ ;
Waugh, JY ;
Smith, CA ;
Goodwin, RG .
IMMUNITY, 1997, 7 (06) :813-820
[8]   Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170
[9]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[10]   AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95) [J].
DHEIN, J ;
WALCZAK, H ;
BAUMLER, C ;
DEBATIN, KM ;
KRAMMER, PH .
NATURE, 1995, 373 (6513) :438-441